Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

This page's audience real numbers from our own analytics — open to see them
–Visitors
–Page views
–Clicks to vendors
–Time on page
–Reading now
Clicks to vendors, by tool
  • –
Top countries
  • –
Devices
  • –

– · counted by iTechGuides's own first-party analytics, bots removed, every figure rounded down · how we count

AlgoraeOS

#29 of 30 in AI Drug Discovery Software

AlgoraeOS: A specialist platform for enterprise teams modeling drug combinations and synergy. Ranked #29 of 30 in AI Drug Discovery Software by our editors (5.4/10); pricing: Pricing on request; best for enterprise teams exploring drug combinations.

5.4/10Editor score
AlgoraeOS5.4 Contact Algorae

At a glance

  • Editor score
    5.4 / 10
  • Pricing
    Pricing on request
  • Best for
    Enterprise teams exploring drug combinations
  • Facts checked
    4 Oct 2026
  • Where it wins

    • Generates drug-combination candidates from connected biomedical data
    • Predicts outcomes across drug and cell-line combinations
    • Models dose-response synergy with Bliss, Loewe, HSA and ZIP
  • Where it doesn't

    • Narrowly focused on drug combinations rather than broader discovery workflows
    • Pricing requires contacting sales
    • A platform research publication is listed as pending

Our verdict on AlgoraeOS

AlgoraeOS is a proprietary AI drug-discovery platform from Algorae Pharmaceuticals Ltd, developed with research partners. It connects preclinical, clinical, chemical and biological data to generate drug-combination candidates for complex disease areas. Its stated audience is enterprise teams exploring combination candidates, particularly pharmaceutical and biotech partners considering candidate validation, licensing or co-development. The focus is on molecule-level discovery rather than a broad drug-development toolset.

Its standout capability is combination modeling. AlgoraeOS predicts drug-cell-line outcomes and models dose-response surfaces using Bliss, Loewe, HSA and ZIP synergy formalisms. The vendor also describes a closed-loop process: discovery and preclinical development data feed back into predictive capability. That makes the platform relevant to teams evaluating combinations against cell-line outcomes and synergy patterns. The published description does not establish broader workflow coverage beyond these functions, so teams seeking a general-purpose discovery environment should compare alternatives with wider scopes.

AlgoraeOS is proprietary, and the pricing model is contact sales, so evaluation begins through a vendor conversation rather than a published plan comparison. Algorae describes candidates as validated with research partners and available for licensing or co-development, which points to a partnership-oriented path for advancing outputs. The official product page lists a research publication as pending, while no peer-reviewed platform publication is identified in the product description. Enterprise groups focused on combination generation and partner-led validation may find the scope aligned with their needs; teams prioritizing public pricing, broader discovery coverage or published platform research should weigh those considerations before engaging.

Your product? Our editors can test AlgoraeOS in depth and publish a review, labelled as paid · from $99/mo →

AlgoraeOS pricing

Plans Pricing on request No free plan — trial or paid only. Prices checked 4 Oct 2026.
See plans on algoraepharma.com

AlgoraeOS fact sheet

Free planNot verified
Paid fromNot verified
Target identificationNot verified
Molecule designNot verified
Drug repurposingNot verified
Discovery scopeMolecule
Deployment optionsNot verified
Research publicationsNo
Built forEnterprise (editorial estimate)
PricingPricing on request
Websitealgoraepharma.com
Facts checked4 Oct 2026

Alternatives to AlgoraeOS

See all AlgoraeOS alternatives →

Used AlgoraeOS? Be the first to review it

The editor score above is our own research. What this page doesn't have yet is a reader's view — what you used AlgoraeOS for, what worked and what didn't. No stars are seeded and no review is paid for; an editor reads every one before it appears.

Write a reviewTwo minutes · verified accounts only · read by an editor before it appears

Reviews come only from verified accounts. Sign in or create an account first — your e-mail is never shown.

Your rating

0 characters · at least 80, up to 3,000

Posted from your verified account. Reviews appear after an editor reads them, usually within two working days.

Featured on iTechGuides

Featured on iTechGuides — AlgoraeOS 5.4/10

AlgoraeOS is listed in our AI Drug Discovery Software directory. Add the badge to your site — it links back to this page.

<a href="https://www.itechguides.com/products/algoraeos/"><img src="https://www.itechguides.com/best/badge/algoraeos.svg" alt="Featured on iTechGuides" width="230" height="46"></a>

Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. How we rank.

Last updated · How we research and update